Cancer News and Research

Latest Cancer News and Research

At 8 million sign-ups, health law enrollment surpasses target

President Barack Obama hailed the latest tally of people who gained insurance as a result of the health law. News outlets also look inside this latest round of data to find out what information the administration is providing and what is still to come.

19 Apr 2014

Pfizer to highlight Blue Button initiative at DIA 2014 Annual Meeting in San Diego

Craig Lipset, head of clinical innovation at Pfizer Inc., will join advocates of patient data accessibility to highlight the Blue Button initiative at the DIA 2014 50th Annual Meeting in San Diego.

18 Apr 2014

Olympus' surgical products named finalists for ATA award

Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.

From Evident Corporation - Life Sciences 18 Apr 2014

WOTV 4's Maranda and Forest Hills Central students honored for contributing to community-based causes

The second annual Carol Van Andel Angel of Excellence dinner and award presentation took place on April 17, 2014. The event, hosted by Van Andel Institute (VAI), honored individuals who have made a significant contribution to the Institute through volunteer service, philanthropy, special event support, innovation or scientific support.

18 Apr 2014

Viewpoints: Obamacare still has more challenges; GOP needs to help make law work; census change is not Obama's decision

The first open enrollment period under the Affordable Care Act ended this week with roughly 7.5 million people obtaining policies through the new state insurance exchanges, including more than 1.3 million at Covered California.

18 Apr 2014

Cyclenium Pharma signs drug discovery and development agreement with Southern Research Institute

Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on proprietary macrocyclic chemistry, today announced the signing of a discovery and co-development agreement with Southern Research Institute, a not-for-profit 501(c)(3) scientific research organization founded in 1941.

18 Apr 2014

Drug used to treat TB may also act against various infections, says study

A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a study by University of Illinois chemists and collaborators.

18 Apr 2014

Engineering cell-based, biological devices may selectively kill cancer cells without disrupting healthy cells

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other sites of disease.

18 Apr 2014

Men with chronic inflammation in non-cancerous prostate tissue may have nearly twice risk of prostate cancer

Men who show signs of chronic inflammation in non-cancerous prostate tissue may have nearly twice the risk of actually having prostate cancer than those with no inflammation, according to results of a new study led by researchers from the Johns Hopkins Kimmel Cancer Center.

18 Apr 2014

Skin docs prescribe costlier drugs after free samples

In other news, panels recommend a costly hepatitis C drug for the sickest patients, and cancer doctors will compare the value of costly cancer drugs.

18 Apr 2014

XBiotech announces results from Phase I/II oncology study

XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, TX were published today in Lancet Oncology. The featured article describes the outcome in 52 advanced cancer patients treated with Xilonix™, XBiotech's novel, non-cytotoxic, anti-tumor therapy.

18 Apr 2014

Study: Chronic inflammation associated with aggressive prostate cancer

The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

18 Apr 2014

Queen's University professor elected as Fellow of European Academy of Cancer Sciences

Queen's University Belfast's Vice-Chancellor, Professor Patrick Johnston, whose work has transformed cancer care in Northern Ireland, has been elected as a Fellow of the European Academy of Cancer Sciences.

18 Apr 2014

B1/Cdk1 protein which plays key role in cell division also boosts power of mitochondrial activity

An international team led by researchers at UC Davis has shown that the cyclin B1/Cdk1 protein complex, which plays a key role in cell division, also boosts the mitochondrial activity to power that process.

18 Apr 2014

13th annual Bio-IT World Conference & Expo to launch new disciplinary track on data security

The 13th annual Bio-IT World Conference & Expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston, today announced that it will debut a new disciplinary track focused on data security.

18 Apr 2014

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million for the first quarter of 2013. Net loss in the first quarter of 2014 was $(9.3) million, or $(0.13) per share, which compares to net income of $0.3 million, or $0.00 per share, in the first quarter of 2013.

18 Apr 2014

Global cancer profiling market expected to grow $54.8 billion by 2018

Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.

18 Apr 2014

Adrenaline does not boost long-term survival rates in heart attack patients, says study

Giving patients adrenaline after they suffer a cardiac arrest outside of a hospital does not increase their prospects of surviving long-term, according to new research conducted at St. Michael's Hospital.

18 Apr 2014

Princeton professor receives Agilent Thought Leader Award to research on cellular metabolism activity

Agilent Technologies Inc. today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University's Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, has received an Agilent Thought Leader Award to support his work on quantitative analysis of cellular metabolism.

18 Apr 2014

Agios begins AG-348 Phase 1 study to treat PK deficiency

Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy volunteers.

18 Apr 2014

Cancer News and Research

Latest Cancer News and Research

At 8 million sign-ups, health law enrollment surpasses target

Pfizer to highlight Blue Button initiative at DIA 2014 Annual Meeting in San Diego

Olympus' surgical products named finalists for ATA award

WOTV 4's Maranda and Forest Hills Central students honored for contributing to community-based causes

Viewpoints: Obamacare still has more challenges; GOP needs to help make law work; census change is not Obama's decision

Cyclenium Pharma signs drug discovery and development agreement with Southern Research Institute

Drug used to treat TB may also act against various infections, says study

Engineering cell-based, biological devices may selectively kill cancer cells without disrupting healthy cells

Men with chronic inflammation in non-cancerous prostate tissue may have nearly twice risk of prostate cancer

Skin docs prescribe costlier drugs after free samples

XBiotech announces results from Phase I/II oncology study

Study: Chronic inflammation associated with aggressive prostate cancer

Queen's University professor elected as Fellow of European Academy of Cancer Sciences

B1/Cdk1 protein which plays key role in cell division also boosts power of mitochondrial activity

13th annual Bio-IT World Conference & Expo to launch new disciplinary track on data security

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Global cancer profiling market expected to grow $54.8 billion by 2018

Adrenaline does not boost long-term survival rates in heart attack patients, says study

Princeton professor receives Agilent Thought Leader Award to research on cellular metabolism activity

Agios begins AG-348 Phase 1 study to treat PK deficiency

Understanding the DNA Damage Response in Innate Immunity eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in